Overview
AI INFORM is a multicenter randomized trial that will test the hypothesis that providing clinicians information on the presence and amount of coronary artery calcifications (CAC), will result in initiation or intensification of preventive therapies. The study will use a cloud-based artificial intelligence (AI) platform (Nanox.AI) that can analyze non contrast chest CT and estimate the amount of CAC.
Eligibility
Inclusion Criteria:
- Patients aged between 40-75 with prior chest CT within last 3 years
Exclusion Criteria:
- Prior coronary artery disease
- Prior cancer
- Other life-limiting condition